{"version":"1.2.0","chapters":[{"startTime":0,"title":"Begr\u00fc\u00dfung"},{"startTime":43.521,"title":"Einleitung Herzwirksame Wirkstoffe"},{"startTime":161.077,"title":"Wirkstoffklassen mit positiv inotroper Wirkung"},{"startTime":285.11,"title":"Exkurs Theophyllin"},{"startTime":336.821,"title":"Herzwirksame Glycoside"},{"startTime":523.957,"title":"Struktur der herzwirksamen Glycoside"},{"startTime":808.035,"title":"Digitoxose"},{"startTime":991.068,"title":"Digitoxin"},{"startTime":1050.304,"title":"Digoxin"},{"startTime":1118.756,"title":"Derivate der Glycoside"},{"startTime":1156.326,"title":"Therapeutische Breite des Digitoxin und Digoxin"},{"startTime":1389.592,"title":"Wirkungsmechanismus der Glycoside"},{"startTime":1483.791,"title":"Nebenwirkungen"},{"startTime":1614.056,"title":"Verbreitung der Cardenolide"},{"startTime":1686.224,"title":"Biosynthese des Steroidgrundk\u00f6rpers"},{"startTime":1740.323,"title":"Wirkungsmechanismus der Phosphodiesterase-Hemmer"},{"startTime":1797.68,"title":"Cyclisches AMP"},{"startTime":1998.076,"title":"Bispyridin-Derivate"},{"startTime":2046.024,"title":"Amrinon"},{"startTime":2173.896,"title":"Interaktion mit der PDE-3"},{"startTime":2215.171,"title":"Milrinon"},{"startTime":2258.657,"title":"Enoximon"},{"startTime":2363.305,"title":"Lacton,Lactam und Thiolacton"},{"startTime":2443.499,"title":"Cilostazol"},{"startTime":2564.347,"title":"Antianginosa"},{"startTime":2717.421,"title":"NO-Pharmka"},{"startTime":2893.329,"title":"Wirkung von NO"},{"startTime":3258.626,"title":"Nitroglycerin"},{"startTime":3407.088,"title":"Pentaerythrityltetranitrat"},{"startTime":3468.975,"title":"Isosorbid-Mono bzw. Dinitrat"},{"startTime":3579.236,"title":"Molsidomin"},{"startTime":3707.919,"title":"Umlagerung von Molsidomin"},{"startTime":3916.47,"title":"Poppers"},{"startTime":4115.685,"title":"Verabschiedung und Bitte um Feedback"}]}